Edition:
India

Chromadex Corp (CDXC.OQ)

CDXC.OQ on NASDAQ Stock Exchange Capital Market

3.49USD
10:25pm IST
Change (% chg)

$0.10 (+2.95%)
Prev Close
$3.39
Open
$3.35
Day's High
$3.50
Day's Low
$3.35
Volume
65,144
Avg. Vol
45,392
52-wk High
$7.24
52-wk Low
$3.19

Latest Key Developments (Source: Significant Developments)

Chromadex Says Tru Niagen Daily Serving Strengthened Under FDA NDI Notification
Wednesday, 24 Oct 2018 

Oct 24 (Reuters) - Chromadex Corp ::TRU NIAGEN® DAILY SERVING STRENGTHENED UNDER FDA’S NDI NOTIFICATION.CHROMADEX - STRENGTHENED FLAGSHIP TRU NIAGEN (NICOTINAMIDE RIBOSIDE) NUTRIENT TO 150MG CAPSULES, TWO PER DAY.  Full Article

Chromadex Corp Appoints Rob Fried as Chief Executive Officer
Tuesday, 24 Apr 2018 

April 23 (Reuters) - Chromadex Corp ::CHROMADEX APPOINTS FRANK JAKSCH AS EXECUTIVE CHAIRMAN, ROB FRIED AS CHIEF EXECUTIVE OFFICER AND KURT GUSTAFSON AS LEAD DIRECTOR.CHROMADEX CORP - JAKSCH SUCCEEDS STEPHEN ALLEN.CHROMADEX CORP - FRIED WILL SUCCEED FRANK JAKSCH AS CEO.  Full Article

Chromadex Files For Resale Of Up To 5.6 Mln Shares Of Common Stock By The Selling Stockholders
Friday, 15 Dec 2017 

Dec 14 (Reuters) - Chromadex Corp ::CHROMADEX CORP FILES FOR RESALE OF UP TO 5.6 MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING.  Full Article

ChromaDex Q3 loss per share $0.07 from continuing operations
Friday, 10 Nov 2017 

Nov 9 (Reuters) - ChromaDex Corp ::ChromaDex reports third quarter 2017 financial results.Q3 loss per share $0.07 from continuing operations.Q3 sales rose 55 percent to $6.1 million.  Full Article

Chromadex announces $23 mln private placement of common stock
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Chromadex Corp :Chromadex announces $23 million private placement of common stock.Chromadex Corp - in connection with investment, co agreed to sell 5.6 million shares of common stock at a per share price of $4.10​.Chromadex Corp - ‍net proceeds of investment expected to provide co added resources to accelerate plans related to nad+ in general, tru niagen in particular​.  Full Article

Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 mln
Wednesday, 1 Nov 2017 

Oct 31 (Reuters) - Chromadex Corp :Chromadex Corp files for common stock‍​ offering by selling stockholders of up to $7.7 million - SEC filing.  Full Article

Chromadex appoints Kevin Farr as new CFO
Monday, 9 Oct 2017 

Oct 9 (Reuters) - Chromadex Corp :Chromadex appoints Kevin Farr as new CFO.Chromadex Corp says ‍Chromadex expects that Thomas Varvaro will transition from Chromadex over coming months to pursue other opportunities​.  Full Article

Chromadex Q4 loss per share $0.06
Friday, 17 Mar 2017 

Chromadex Corp : Chromadex reports 2016 record revenue as ingredient sales grew 34% . Q4 loss per share $0.06 .Q4 sales rose 29 percent to $5.6 million.  Full Article

Chromadex sees Q4 revenue of about $5.6 mln
Tuesday, 14 Feb 2017 

Chromadex Corp : Chromadex expects to report record fourth quarter as revenue increased approximately 29% . Sees Q4 2016 revenue about $5.6 million .Sees FY 2016 revenue about $26.8 million.  Full Article